Ninth Circuit Revives False Claims Act Suit Against Valeant Pharmaceuticals
The United States Ninth Circuit Court of Appeals has revived a lawsuit under the False Claims Act (FCA), that accuses Valeant Pharmaceuticals of fraudulently acquiring a patent to prolong the monopoly over its drug Apriso. The suit had initially been dismissed because of the rule known as the ‘public disclosure bar’ – a federal rule…